GTR Home > Tests > Search results - Congenital generalized lipodystrophy type 1

Apply filters

Showing test for 1 condition

reset

Compare labs

  • Hide states

GTR test search results for C1720862[DISCUI]

C Clinical test, R Research test

Showing 1 to 6 of 6 tests for 1 condition in 3 labs

CLipodystrophy congenital generalized type 1

Lab: Centogene AG - the Rare Disease Company University of Rostock Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CCongenital Generalized Lipodystrophy Type 1 via the AGPAT2 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CCongenital Generalized Lipodystrophy Types 1 and 2 Sanger Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CAGPAT2

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CCongenital Generalized Lipodystrophy Type 1/2 NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (5)

CLipodystrophy NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (38)
Total targets (10)

Showing 1 to 6 of 6 tests for 1 condition in 3 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.